Tilray Inc (TLRY) - Cash Flow Conversion Efficiency

Latest as of February 2026: -0.014x

Based on the latest financial reports, Tilray Inc (TLRY) has a cash flow conversion efficiency ratio of -0.014x as of February 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-21.94 Million ≈ $-15.87 Million USD) by net assets (CA$1.53 Billion ≈ $1.10 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Tilray Inc - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Tilray Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Tilray Inc (TLRY) financial obligations for a breakdown of total debt and financial obligations.

Tilray Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tilray Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Beijing Jingcheng Machinery Electric Co Ltd SHG:600860	0.058x
Cullinan Oncology LLC NASDAQ:CGEM	-0.082x
China Master Logistics Co Ltd SHG:603967	0.060x
Sella Real Estate TA:SLARL	0.021x
Media and Games Invest PLC F:M8G	0.001x
Velocity Financial Llc NYSE:VEL	0.018x
Zhejiang Feida Environmental Science & Technology Co Ltd SHG:600526	0.065x
Baotek Industrial Materials Ltd TWO:5340	0.070x

Annual Cash Flow Conversion Efficiency for Tilray Inc (2012–2025)

The table below shows the annual cash flow conversion efficiency of Tilray Inc from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Tilray Inc (TLRY) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-05-31	CA$1.49 Billion ≈ $1.08 Billion	CA$-94.60 Million ≈ $-68.43 Million	-0.064x	-607.55%
2024-05-31	CA$3.44 Billion ≈ $2.49 Billion	CA$-30.91 Million ≈ $-22.36 Million	-0.009x	-478.05%
2023-05-31	CA$3.33 Billion ≈ $2.41 Billion	CA$7.91 Million ≈ $5.72 Million	0.002x	+105.95%
2022-05-31	CA$4.44 Billion ≈ $3.21 Billion	CA$-177.26 Million ≈ $-128.23 Million	-0.040x	-298.55%
2021-05-31	CA$4.47 Billion ≈ $3.23 Billion	CA$-44.72 Million ≈ $-32.35 Million	-0.010x	+86.24%
2020-05-31	CA$1.33 Billion ≈ $958.73 Million	CA$-96.43 Million ≈ $-69.76 Million	-0.073x	-126.78%
2019-05-31	CA$1.28 Billion ≈ $926.63 Million	CA$-41.10 Million ≈ $-29.73 Million	-0.032x	-566.53%
2018-05-31	CA$910.14 Million ≈ $658.38 Million	CA$-4.38 Million ≈ $-3.17 Million	-0.005x	-124.75%
2017-05-31	CA$203.29 Million ≈ $147.06 Million	CA$3.95 Million ≈ $2.86 Million	0.019x	+168.90%
2016-05-31	CA$26.85 Million ≈ $19.42 Million	CA$-757.62K ≈ $-548.05K	-0.028x	+93.08%
2015-05-31	CA$10.74 Million ≈ $7.77 Million	CA$-4.38 Million ≈ $-3.17 Million	-0.408x	-169.35%
2014-05-31	CA$271.84K ≈ $196.64K	CA$-41.16K ≈ $-29.78K	-0.151x	0.00%
2013-05-31	CA$271.84K ≈ $196.64K	CA$-41.16K ≈ $-29.78K	-0.151x	-17.18%
2012-05-31	CA$333.15K ≈ $241.00K	CA$-43.05K ≈ $-31.14K	-0.129x	--

About Tilray Inc

TO:TLRY Canada Drug Manufacturers - Specialty & Generic

Market Cap

$706.51 Million

CA$976.68 Million CAD

Market Cap Rank

#10806 Global

#304 in Canada

Share Price

CA$8.38

Change (1 day)

-1.06%

52-Week Range

CA$0.50 - CA$19.12

All Time High

CA$26.00